BBOTVSLEXX• 28 Days (Normalized)
BBOT vs LEXX (BridgeBio Oncology Therapeutics Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.68%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
LEXX Performance $2.88
-79.65%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+22.97 pts
BBOT outperforming by 22.97 percentage points
BBOTLEXX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | BBOT Price | BBOT Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.68% | $2.88 | -79.65% | +22.97% |
| Sep 30, 2026 | $4.10 | -54.34% | $3.15 | -77.74% | +23.40% |
| Sep 29, 2026 | $3.92 | -56.35% | $3.13 | -77.88% | +21.53% |
| Sep 28, 2026 | $3.81 | -57.57% | $3.23 | -77.21% | +19.64% |
| Sep 25, 2026 | $3.95 | -56.01% | $3.28 | -76.82% | +20.81% |
| Sep 24, 2026 | $3.99 | -55.57% | $3.37 | -76.18% | +20.61% |
| Sep 23, 2026 | $4.16 | -53.67% | $3.24 | -77.14% | +23.47% |
| Sep 22, 2026 | $4.66 | -48.11% | $- | - | |
| Sep 21, 2026 | $4.66 | -48.11% | $3.43 | -75.80% | +27.69% |
| Sep 18, 2026 | $4.77 | -46.88% | $3.24 | -77.10% | +30.22% |
| Sep 17, 2026 | $4.89 | -45.55% | $3.29 | -76.75% | +31.20% |
| Sep 16, 2026 | $4.76 | -46.99% | $3.10 | -78.13% | +31.14% |
| Sep 15, 2026 | $4.88 | -45.66% | $3.21 | -77.31% | +31.65% |
| Sep 14, 2026 | $5.05 | -43.76% | $3.55 | -74.91% | +31.15% |
| Sep 11, 2026 | $4.95 | -44.88% | $3.97 | -71.94% | +27.06% |
Page 1 of 2